Adalimumab-Bwwd
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Adalimumab-Bwwd is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $7 million on Adalimumab-Bwwd across 6,000 claims for 1,317 beneficiaries.
Adalimumab-Bwwd is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $622.76 to $1258.83 per ML — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$622.76 – $1258.83
per ML
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ADALIMUMAB-BWWD
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HADLIMA(CF) PUSHTOUCH 40 MG/0.4 ML | $1258.8340 per ML | -0.12% |
HADLIMA(CF) 40 MG/0.4 ML SYRINGE | $1254.6130 per ML | -0.01% |
HADLIMA PUSHTOUCH 40 MG/0.8 ML | $622.7586 per ML | — |
Frequently Asked Questions
What is Adalimumab-Bwwd used to treat?
Adalimumab-Bwwd is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Bwwd?
In 2024, Medicare Part D spent $7 million on Adalimumab-Bwwd across 6,000 claims for 1,317 beneficiaries.
How many Adalimumab-Bwwd products are on the market?
The Adalimumab-Bwwd drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Adalimumab-Bwwd?
NADAC reference prices for Adalimumab-Bwwd range from $622.7586 to $1258.8340 per ML — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Adalimumab-Bwwd?
1 manufacturer lists Adalimumab-Bwwd in NADAC. Ranked by number of NDCs, the largest are Organon LLC (3).
How has the price of Adalimumab-Bwwd changed recently?
Over the past 7 days, 0 Adalimumab-Bwwd NDCs rose and 2 fell, with a market-wide average change of -0.1%.